NCT05026229 2021-10-01
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
First Affiliated Hospital Xi'an Jiaotong University
Gruppo Italiano Malattie EMatologiche dell'Adulto
National Cancer Institute (NCI)